Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2001-05-16
2004-09-21
Qazi, Sabiha (Department: 1616)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C540S088000
Reexamination Certificate
active
06794503
ABSTRACT:
FIELD OF THE INVENTION
The present invention refers to a stereoselective process for the preparation of 6&agr;-fluorosteroids of formula (I) reported hereinafter, useful in the preparation of anti-inflammatory pharmaceutical formulations.
PRIOR ART
The availability of a process for the preparation of pregnane fluoro derivatives, which might predominantly yield 6&bgr;-fluoro substituted isomers, well known anti-inflammatory agents, is very important from a pharmacological point of view, since the corresponding 6&bgr;-fluoro derivatives do not exert any pharmacological action.
Many procedures for the preparation of 6-fluoro pregnane derivatives have been developed so far; however, all of them yield mixtures of the two isomers in relatively high 6&bgr;/6&agr; ratios. It follows that the conversion of isomer 6&bgr; into isomer 6&agr; or repeated purifications are required to obtain the pharmacologically active isomer only.
By way of example, U.S. Pat. No. 2,961,441 discloses the preparation of 6&bgr;-fluoro-3-keto-&Dgr;
4
-pregnenes by fluorination of the corresponding 3-enol esters with perchloryl fluoride, in an inert organic solvent and in the presence of a catalyst. In particular, said patent describes the fluorination on 3,17&agr;,21-triacetoxy derivative. The process yields 6&bgr;-fluoro substituted compounds, which are converted into the corresponding 6&agr; isomers by methods known in the art.
U.S. Pat. No. 3,980,778 describes the preparation of the 6&agr;,9&agr;-difluoro pregnane derivative of formula
by fluorination, with perchloryl fluoride, of 3,17&agr;,21-trihydroxy-16&bgr;-methylpregna-3,5,9-(11)-trien-20-one 3,17,21-triacetate, obtained by causing to react the corresponding 17&agr;,21-dihydroxy-16&bgr;-methylpregna-4,9(11)-diene-3,20-dione 21 acetate with isopropenyl acetate.
Said process yields a 6&bgr;/6&agr; isomeric mixture in which isomer 6&bgr; predominates. It follows that, with a view to obtaining a pharmaceutically useful final product, the 6&bgr;-fluorosteroid is to be converted into the corresponding 6&agr;-fluoro compound.
In all aforementioned cases, the formation of 3-enol ester, necessary for the steroid activation at the 6-position, brings about the simultaneous acetylation of the hydroxy groups, if any, at 17&agr;- and 21-positions.
Said processes suffer from a number of disadvantages; for example they are not stereoselective and require the use of perchloryl fluoride as a fluorinating agent, an esplosive and highly corrosive reagent that must be handled with special care and must be used with very long reaction times.
The use of other fluorinating agents, such as for example Selectfluor®, Accufluor® NFSi or Accufluor® NFTh, on the described substrates yields mixtures with still more unfavourable 6&agr;:6&bgr; ratios.
Therefore, the need for a process for the preparation of 6&agr;-fluorosteroids, free from the disadvantages of the processes known in the art, is deeply felt.
SUMMARY
It has surprisingly been found that a high stereoselectivity of the fluorination at the 6-position can be obtained by operating on substrates obtained in order that the 17&agr;-hydroxy group remains unreacted, and by using specific fluorinating agents. It is, therefore, an object of the present invention to provide a process for the preparation of 6&agr;-fluorosteroids of formula (I)
wherein R is a substituent at the &agr;- or &bgr;-position, chosen from H, OH and an alkyl group with from 1 to 4 carbon atoms, R′ is a carboxyalkyl group with from 1 to 4 carbon atoms in the alkyl chain and wherein a double bond may be present between positions 1 and 2, said process comprising the reaction of the compound of formula (III) with an electrophilic fluorinating agent to give the compound of formula (I)
wherein R and R′ are as defined above, and wherein said electrophilic fluorinating agent is selected from the group consisting of N-fluoro N-chloromethyl triethylenediamine bis-tetrafluoroborate, 1-fluoro-4-hydroxy-1,4-diazabicyclo[2.2.2]octane-bis-tetrafluoroborate, and 1-fluoro-benzenesulfonamide.
The characteristics and advantages of the process of the present invention will be apparent from the detailed description reported herein.
REFERENCES:
patent: 2838548 (1958-06-01), Schneider et al.
patent: 2961441 (1960-11-01), Bogert et al.
patent: 3207751 (1965-09-01), Pinson, Jr.
patent: 3557158 (1971-01-01), Lincoln et al.
patent: 3980778 (1976-09-01), Ayer et al.
patent: 4188322 (1980-02-01), Castell et al.
patent: 4255331 (1981-03-01), MacDonald
patent: 4619921 (1986-10-01), Kalvoda et al.
patent: 5478957 (1995-12-01), Godard et al.
patent: 5556965 (1996-09-01), Godard et al.
Da Col Marco
La Loggia Filippo
Farmabios S.r.l.
Hedman & Costigan ,P.C.
Qazi Sabiha
LandOfFree
Process for the preparation of fluorosteroids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of fluorosteroids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of fluorosteroids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3202641